Metoprolol tartrate
- Product NDC
- 68071-3263
- 11-digit product format
- 680713263
- Labeler code
- 68071
- Product ID
- 68071-3263_505e8cdf-25e5-2a2a-e054-00144ff88e88
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metoprolol tartrate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA076670
- Marketing category
- ANDA
- Marketing start
- 2015-06-29
- Marketing end
- 0000-00-00
- Substance
- METOPROLOL TARTRATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-3263-3 | 2020-05-08 | C162847 | 48780-1 | 9d75b9d0-8281-f424-e053-dadaa90a57ce | 505e8cdf-25e4-2a2a-e054-00144ff88e88 |
| 68071-3263-6 | 2020-05-08 | C162847 | 48780-1 | 9d75b9d0-8281-f424-e053-dadaa90a57ce | 505e8cdf-25e4-2a2a-e054-00144ff88e88 |
| 68071-3263-8 | 2020-05-08 | C162847 | 48780-1 | 9d75b9d0-8281-f424-e053-dadaa90a57ce | 505e8cdf-25e4-2a2a-e054-00144ff88e88 |
| 68071-3263-9 | 2020-05-08 | C162847 | 48780-1 | 9d75b9d0-8281-f424-e053-dadaa90a57ce | 505e8cdf-25e4-2a2a-e054-00144ff88e88 |
| 68071-3263-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8281-f424-e053-dadaa90a57ce | 505e8cdf-25e4-2a2a-e054-00144ff88e88 |
| 68071-3263-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8281-f424-e053-dadaa90a57ce | 505e8cdf-25e4-2a2a-e054-00144ff88e88 |
| 68071-3263-8 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8281-f424-e053-dadaa90a57ce | 505e8cdf-25e4-2a2a-e054-00144ff88e88 |
| 68071-3263-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8281-f424-e053-dadaa90a57ce | 505e8cdf-25e4-2a2a-e054-00144ff88e88 |